News
Interview: Empower Pharmacy CHRO Valerie Capers Workman
8+ hour, 26+ min ago (1783+ words) I recently went one-on-one with Valerie Capers Workman, Chief Human Resources Officer of Empower Pharmacy. Valerie previously served as Vice President of People at Tesla, reporting directly to Elon Musk, and as Chief Talent Engagement Officer at Handshake. Adam: Long…...
Max Healthcare seeks re-classification of Radiant Life Care Hospital Foundation to public category
6+ hour, 6+ min ago (211+ words) Business Upturn Press ESC to close " " to search Max Healthcare Institute has submitted an application to the National Stock Exchange of India Limited and BSE Limited to re-classify Radiant Life Care Hospital Foundation from the "Promoter Group" to the "Public…...
Max Healthcare Update on Radiant Life Care Hospital Foundation Re-classification
6+ hour, 5+ min ago (212+ words) Investy Wise Max Healthcare Update on Radiant Life Care Hospital Foundation Re-classification Max Healthcare Institute Limited has formally submitted an application to stock exchanges to re-classify Radiant Life Care Hospital Foundation from the "Promoter Group" to the "Public" category. This…...
Zydus Lifesciences Reports Robust Q4 FY26 Results with Double-Digit Growth
6+ hour, 56+ min ago (410+ words) Investy Wise Zydus Lifesciences Reports Robust Q4 FY26 Results with Double-Digit Growth Zydus Lifesciences concluded fiscal year 2026 on a high note, delivering strong double-digit growth across key business segments. Consolidated annual revenue reached "271. 5 billion, a 17% year-on-year increase, while operating profit grew by…...
Acacia IT system architect moved on as Health CEO
7+ hour, 9+ min ago (25+ words) NT Independent Acacia IT system architect moved on as Health CEO Submit a Comment Cancel reply...
Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.
37+ min ago (523+ words) When macro volatility ticks up and tech momentum begins to feel fragile, the Health Care Select Sector SPDR Fund (XLV) is routinely prescribed as the ultimate defensive remedy. This time around, XLV seems like an especially effective treatment for portfolio maladies....
Gilead Sciences: $3. 15 Billion Tubulis Acquisition Completed To Strengthen Oncology And ADC Portfolio
1+ hour, 6+ min ago (229+ words) Under the terms of the agreement, Gilead acquired all outstanding equity of Tubulis for $3. 15 billion in upfront consideration on a cash-free, debt-free basis, along with up to $1. 85 billion in contingent milestone payments. The acquisition adds Tubulis" lead ADC candidate TUB…...
Natraj Proteins returns to profit in FY26
7+ hour, 42+ min ago (475+ words) Natraj Proteins Limited reported a net profit of "113. 51 lakh for FY26, reversing the previous year's loss of "146. 27 lakh. Annual income from operations stood at "10112. 13 lakh, while Q4 profit was "110. 84 lakh on revenue of "1887. 26 lakh. Natraj Proteins Limited has announced its audited financial…...
PEB: Revenue fell sharply as US volumes dropped, but Medicare policy momentum and capital raise set up a recovery
1+ hour, 58+ min ago (93+ words) Trading View PEB: Revenue fell sharply as US volumes dropped, but Medicare policy momentum and capital raise set up a recovery FY26 saw a 47% revenue decline and a 20% increase in net loss due to Medicare non-coverage and US product transition, but…...
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference
6+ hour, 4+ min ago (1168+ words) Interested in Gilead Sciences, Inc. ? Here are five stocks we like better. Trodelvy is a key near-term catalyst for Gilead, with management highlighting upcoming data in first-line PD-L1-high non-small cell lung cancer and hoping for a meaningful progression-free survival…...